Business Standard

Tuesday, January 07, 2025 | 08:27 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Disinvestment clouds Bengal Chemicals' growth prospects

16 state govt clients doubt firm's ability to meet supply deals, with Centre undecided on stake sale

graph
Premium

graph

Avishek Rakshit Kolkata
Lack of clarity over the proposed disinvestment in Bengal Chemicals and Pharmaceuticals is threatening its turnaround.

A company executive said 16 state governments that bought generic drugs from Bengal Chemicals were questioning its ability to meet supply contracts as its future was yet to be decided by the Centre.

The Union Cabinet had in December approved strategic equity sales in Bengal Chemicals and Hindustan Antibiotics, in which it holds 100 per cent stakes.

“Questions are being asked by our clients over the future of the company,” the executive said, adding this could dent sales and discourage potential customers.

PM Chandraiah,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in